AllDocs -> cancers

Fifth International Laryngeal Cancer Conference State-of-the-Art in Surgical and Non-surgical Organ Preservation for Laryngeal and Pharyngeal Carcinoma Fifth International Laryngeal Cancer Conference State-of-the-Art in Surgical and Non-surgical Organ Preservation for Laryngeal and Pharyngeal Carcinoma CALL FOR POSTER ABSTRACTS Thursday & Friday March 2-3, 2006 Didactic and Poster Presentation The Rittenhouse Hotel 210 West Rittenhouse Square Philadelphia, PA Saturday March 4, 2006 Hands-on Laser, Robotic Surgery and Cadaver Dissection Campus of the University of Pennsylvania Medical Center 3400 Spruce Street Philadelphia, PA This conference is supported in part by an educational grant from Integral PET Associates, LLC. ...

Web Immagini Gruppi Directory News altro » Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:WFeKAHXsmUQJ:www.siumed.edu/surgery/otol/ppts/organ_preservation_for_laryngeal_cancer.ppt allintitle: laryngeal cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: Assicurarsi che tutte le parole siano state digitate correttamente. Provare con parole chiave diverse. Provare con parole chiave più generiche. Provare ...

Web Immagini Gruppi Directory News altro » Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:nXMkwHHT3tcJ:www.oncolink.upenn.edu/conferences/images/laryngeal03.pdf allintitle: laryngeal cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: Assicurarsi che tutte le parole siano state digitate correttamente. Provare con parole chiave diverse. Provare con parole chiave più generiche. Provare con un numero minore ...

laryngeal cancer 1581 Treatment of laryngeal cancer ( stage I) Supraglottis External beam radiation therapy alone Supraglottic laryngectomy Glottis Radiation therapy Cordectomy (Limited and superficial T1 lesion) Hemi or total laryngectomy Laser excision Subglottis radiation therapy Surgery is reserved for failure of radiation Treatment of laryngeal cancer ( stage II) Supraglottis External beam radiation therapy alone Supraglottic laryngectomy or total laryngectmy Postop. RT for positive or close surgical margin Glottis Radiation therapy Partial or hemilaryngectomy or total laryngectomy Subglottis radiation therapy alone Surgery is reserved for failure of radiation Under clinical evaluation Hyperfractioned radiation therapy Treatment of laryngeal cancer ( stage III) ...

©2005 American Academy of Otolaryngology—Head and Neck Surgery 1 "Listen to your voice! It may be telling you something!" www.entnet.org/news/VoiceDay.cfm 2005 Laryngeal cancer is not as well known by the general public as some other types of cancer , yet it is not a rare disease. The American Cancer Society estimates that in 2005 almost 10,000 new cases of laryngeal cancer will be diagnosed, and close to 3,800 people will die from laryngeal cancer in the United States. Even for survivors, the consequences of laryngeal cancer can be severe with respect to voice, breathing, or swallowing. It is fundamentally a preventable disease though, since the primary risk factors for laryngeal cancer are associated with modifiable behaviors. Risk Factors Associated With Laryngeal Cancer Development of laryngeal cancer is a process that involves many factors, ...

cancer 1 Survival Analysis for a Cancer Clinical Trial Weiming Ke Department of Mathematics and Statistics South Dakota State University September 1, 2005 2 Outline Introduction Study objectives Data Description Statistical Methods Statistical Analysis Conclusion 3 Introduction In this project, some statistical methods for survival analysis were used to analyze the data from a cancer clinical trial. In this clinical trial, the patients were randomly assigned to two treatment groups. The survival time (months) to disease progression were recorded for each patient. The time to disease progression is the length of time between starting treatment and the cancer progressing. 4 Introduction (cont.) ...

Sponsored by: Co-Presented by: Fourth International Laryngeal Cancer Conference State-Of-The-Art in Surgical and Non-Surgical Organ Preservation for Laryngeal and Pyriform Sinus Carcinoma Fourth International Laryngeal Cancer Conference State-Of-The-Art in Surgical and Non-Surgical Organ Preservation for Laryngeal and Pyriform Sinus Carcinoma CALL FOR POSTER ABSTRACTS This conference is supported in part by an unrestricted educational grant from Siemens Medical Solutions. Thursday & Friday March 11-12, 2004 Didactic and Poster Presentation at The Rittenhouse Hotel 210 West Rittenhouse Square Philadelphia, PA Saturday March 13, 2004 Hands-on Laser and Cadaver Dissection CONFERENCE DIRECTOR Gregory S. Weinstein, MD CONFERENCE ...

Received: 11/9/2004 Accepted: 2/16/2005 Journal of Research in Medical Sciences; Vol. 10, No. 3; May & June 2005 185 Letter to Editor Evaluating hoarseness in early diagnosis of laryngeal cancer To the Editor: We would like to point out that direct laryngo- scopy is the gold standard in the work up of hoarseness and it should be performed in all pa- tients whom the diagnosis cannot be established by other methods. In our experience , we evaluated 363 patients suffering from more than two weeks hoarseness by direct laryngoscopy. Biopsy was obtained for lesions discovered in the larynx or hypopharynx. In 232 patients (64 %), definite diagnosis was made by macroscopic evaluations (direct laryngo- scopy only) but in 131 patients (36 %) biopsy was done to ascertain final diagnosis. Macroscopic evaluation showed normal find- ings in 134 ...

Umesh Kapil et al Asian Pacific Journal of Cancer Prevention, Vol 6, 2005 202 Asian Pacific J Cancer Prev, 6 , 202-207 RESEARCH COMMUNICATION Introduction Cancer continues to be a major health problem despite advances in medical technology for its diagnosis and treatment. Cancer of the larynx is fourteenth most common cancer in the world. In 1996, an estimated 190,000 new cases of laryngeal cancer were diagnosed worldwide, accounting for 1.8 percent of all new cancers (WHO, 1997). Sixty percent of the global incidence of laryngeal cancer is found in developing countries. In India, the incidence of laryngeal cancer has been reported to be 1.3 to 8.8 per 1,00,000 population, in six different regions in the country (ICMR, 1992). Several epidemiological studies suggest that smoking and chewing of tobacco are risk factors for cancer and ...

Chapter 19: Laryngeal cancer 183 Laryngeal cancer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

Treatment of Laryngeal Cancer 116 J HK Coll Radiol 2001;4:116-118 J HK Coll Radiol 2001;4:116-118 INVITED REVIEW The two major modalities for treating laryngeal cancer are surgery and radiation therapy, with the selection of treatment depending on the location of the tumour and the stage of the disease. Computed tomography (CT) and/or magnetic resonance imaging (MRI) of the neck and larynx are routinely used to evaluate patients with laryngeal cancers. Findings from these tests and from physical examination are used to determine the clinical stage of disease. The two major staging systems are the American Joint Committee on Cancer ( AJCC) system 1 and the Inter- national Union Against Cancer ( UICC) staging. 2 Both systems have recently been modified and are essentially the same. A specific change that occurred in the most ...

ENT NEWS • VOLUME 11 NUMBER 4 • SEPTEMBER/OCTOBER 2002 61 Feature A rticle T his question has come up in Head and Neck Clinics up and down the UK dur- ing the last few months as more and more ORL-Head and Neck Surgeons have been trained in, and are experiencing, endoscopic resection of early laryngeal tumours. The answer is that there has been steady progress with significant recent developments. In the early 1990’s several groups, both European and North American, were reporting successful endoscopic treatment of early laryngeal cancer, my own enthusiasm being fired during a world congress in laryngeal cancer held in Sydney in 1990. The increasing numbers of case series reported in conjunction with other laryngeal oncological issues stimulated the first UK evi- dence based meeting in Newcastle on Tyne in 1997. One of the many commendable aspects of ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN LARYNGEAL & PHARYNGEAL CANCER TISSUE MICROARRAY Catalog Number: TMA-017 Each core from each tissue represents one specimen selected and pathologically confirmed. Normal matched or unmatched tissue is provided for comparison to the cancer tissue. Cases : 40 Cores : 80 Diameter : 1.5 mm Thickness: 5 µm Standard IHC: Cytokeratin confirmed Layout : 8 x 10 1 2 3 4 5 6 7 8 9 10 A 1 2 3 4 5 6 7 8 9 10 B 11 12 13 14 15 16 17 18 19 20 C 21 22 23 24 25 26 27 28 29 ...

262 Rogowski M, et al. 263 Loss of heterozygosity in laryngeal cancer Abstract Purpose: Head and neck cancers account for about 6% of all human cancers. Molecular changes leading to the disease development and progression still remain not fully explained. Examination of loss of heterozygosity (allelic loss, LOH) using the specific microsatellite markers is a method of choice in assessing tumour suppressor genes (TSGs) localisation in human genome. Material and methods: The study was performed in a group of 46 male patients, aged 42 - 77 years. Forty three patients underwent total laryngectomy with lymph nodec- tomy, two patients – chordectomy and one patient – partial laryngectomy. Tumour tissue specimens and reference periphereal blood samples were obtained during surgical resections. Standard methods were used for DNA isolation. Fluores- ...

85 An evaluation of laryngeal cancer morbidity time trends in Lithuania Roczniki Akademii Medycznej w Bialymstoku · Vol. 48, 2003 · Annales Academiae Medicae Bialostocensis ADDRESS FOR CORRESPONDENCE: Lilija Jasevi ien , PhD, Thoracic Surgery Department, Head and Neck Division Institute of Oncology of Vilnius University Santari ki – 1, Vilnius, Lithuania tel.: +370 687 95420 fax: +370 5278766 e-mail: irmantas.jasevicius@vuw.lt Received 22.04.2003 Accepted 29.05.2003 Abstract Purpose: To make assessments of the rates of cases of larynx cancer in Lithuania in the years 1978-2001 as well as possible trends of changes in the future. Material and methods: The data contained in the Lithu- anian Cancer Register for the period 1978-2001 about new cases as well as the data compiled by the Lithuanian Department of Statistics on the average ...

Laryngeal Cancer What you need to know Let's Make Cancer History 1 888 939-3333 | www. cancer. ca Page 2 LARYNGEAL CANCER What you need to know Even though we hear about cancer almost every day,when you are diagnosed with cancer you may feel alone and afraid.You may also feel overwhelmed by all the information you are given and by the need to make so many decisions. This publication will give you and your family introductory information you need when you first learn that you have laryngeal cancer ( cancer of the layrnx).It will help you gain a sense of control and help you work with your healthcare team to choose the best treatments for you. Page 3 What is cancer? Cancer is a disease that starts in our cells.Our bodies are made up of millions ...

Laser surgery for T1 laryngeal cancer Satoshi Kitahara * , Tetsuya Tanabe, Yoko Kitagawa, Yuko Matsumura, Etsuyo Tamura Department of Otolaryngology, National Defense Medical College, 3-2 Namiki Tokorozawa, Saitama 359-8513, Japan Abstract We reported the result of laser surgery for T1 laryngeal cancer and discussed its effectiveness. Subjects were 84 cases who had been treated for T1 laryngeal cancer by laser surgery at Otolaryngology of National Defense Medical College Hospital. There were 2 supraglottic cases, 73 glottic, and 9 recurrent glottic after irradiation. Out of 47 cases with T1a glottic cancer, 38 cases were treated by laser alone and 9 were by laser and irradiation. One of 38 cases by laser alone resulted in local recurrence. Out of 26 with T1b, 14 were treated by laser alone and 12 were by laser and irradiation. One of 14 cases of laser resulted in local ...

MJA Vol 176 4 February 2002 113 MEDICINE AND THE LAW The Medical Journal of Australia ISSN: 0025-729X 4 February 2002 176 _ 113-116 ©The Medical Journal of Australia 2002 www.mja.com.au MEDICINE AND THE LAW I N A RECENT DECISION of the Supreme Court of New South Wales, Sharp v Port Kembla RSL Club Ltd , an employee recovered damages from her employer on the basis that exposure to environmental tobacco smoke (ETS) in the course of her employment caused, or materially contributed to, the development of laryngeal cancer (see Box 1 for the plaintiff’s occupational and clinical history). The plaintiff had brought her claim against two employers; one claim was settled out of court and the other proceeded. The decision is noteworthy not so much because it extends medicolegal recognition of cancer causation by ETS beyond the lung, but ...

) 1100 Discussion COFFEE 1125 - 1145 Radiotherapy or Partial laryngectomy for early laryngeal cancers? Chair Dr JS Tobias / Mr P Rhys Evans 1145 - 1310 1145 DXT: doses, fractionation, acceptable delay; morbidity Dr CG Kelly (Page 21) 1205 High quality imaging for treatment planning Mr JC Watkinson (Page 31) 1225 Partial Laryngectomy Mr G Buckley (Page 36) 1245 Discussion LUNCH 1310-1400 Afternoon: Advanced Cancer Beyond Total Laryngectomy Chairs Prof N Stafford / Dr RH MacDougall 1400- 1500 1400 The case for primary radiotherapy in T3 lesions Dr P Dyson (Page 48) 1415 Discussion 1420 Subtotal ...

86 DIFFERENTIAL EXPRESSION PATTERN OF uPA AND CATHEPSIN D IN LARYNGEAL CANCER: POTENTIAL CLINICAL IMPLICATIONS G.Leto*,F.M. Tumminello,M. Crescimanno,C. Flandina,L. Crosta,N. Gebbia Tumor Markers Lab., Service of Chemotherapy, Regional Reference Center for Biomolecular Characterization of Neoplastic Diseases and Genetic Screening of Ereditary Tumors. Azienda Ospedaliera-Universitaria P. Giaccone, 90127 Palermo, Italy Objective: The expression levels and the potential prognostic significance of serine proteinase Urokinase-type Plasminogen Activator (uPA) and lysosomal aspartic proteinase Cathepsin D (CD) were evaluated in patients with locally advanced laryngeal squamous cell carcinoma (LSCC). Methods: uPA and CD levels were determined by immunoluminometric or immunoenzymatic assay in tumor tissues and in the corresponding adjacent normal mucosa (NLM) from 57 patients (56 male, 1 female; ...

INTRODUCTION alignant diseases are diseases with high case-fatality rates. In overall cause of mortality they are second, following the cardiovascular diseases, constituting 18% of all diseases. Laryngeal carcinoma is not a disease with high frequency, and although the larynx is part of the respiratory tract, malignant tumors at this location are less frequent than the carcinomas of the lower part of the respiratory tract. Laryngeal cancer consti- tutes 1-3% of all malignant tumors, but in the head and neck region it constitutes 20% of all tumors and is the most frequent in this region. The incidence of malignant tumor of the larynx in males is on the sixth place in the province of Vojvodina, while in females, it is not in the ten most frequent (1). The province of Vojvodina was included in the registrations of the malignant diseases in the world as early as 1904. However, the data of malignant ...

n engl j med 350;10 www.nejm.org march 4, 2004 The new england journal of medicine 1049 correspondence Nonsurgical Treatment of Laryngeal Cancer to the editor: Forastiere and colleagues (Nov. 27 issue) 1 are to be congratulated on their important study of concurrent chemotherapy and radiotherapy for organ preservation in patients with advanced la- ryngeal cancer. However, the final sentence of their report, which states that they “believe that in most patients with laryngeal cancer, the disease can be managed without a primary surgical approach,” lacks balance and may be misleading to readers. This study included a limited subgroup of patients with advanced laryngeal cancer, whose only surgi- cal option was total laryngectomy. However, there is a large group of patients with advanced laryngeal ...

Laryngeal Cancer Laryngeal cancer is a malignant tumor of the larynx. The larynx is also called the voice box and is located at the top of the windpipe (trachea). The larynx is used to talk, swallow, and breath. How common is laryngeal cancer? In the U.S., over 12,000 people a year are diagnosed with cancer of the larynx. Most of those diagnosed are over the age of 55. Laryngeal cancer is four times more common in men than women. African-Americans are also more commonly affected than Caucasians. What are the causes of laryngeal cancer? Many factors are involved in the development of cancer. The most dominant risk factor for cancer of the larynx is cigarette smoke. The risk is proportional to the amount of exposure to tobacco smoke. Smokers who also drink alcohol heavily are at an increased risk for the development of laryngeal cancer. Smokers can markedly ...